Naltrexone in the treatment of opioid-dependent pregnant women: common ground (Q44337596)

2 December 2017

Naltrexone in the treatment of opioid-dependent pregnant women: common ground (English)

1 reference

2 December 2017

0 references

0 references

1 reference

1 reference

2

1 reference

2 December 2017

4

Mishka Terplan

1 reference

2 December 2017

1

Hendrée E Jones

1 reference

2 December 2017

Lauren M Jansson

3

1 reference

PubMed ID

23331881

2 December 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

2 December 2017

1 reference

2 December 2017

108

1 reference

2 December 2017

2

1 reference

2 December 2017

255-256

1 reference

Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?

2 December 2017

1 reference

Is sustained release natrexone an option for heroin-dependent pregnant women?

21 January 2018

1 reference

Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research

21 January 2018

1 reference

Blocking endogenous opioids during development--do we understand the consequences?

21 January 2018

1 reference

The fetus as a patient: an essential concept for the ethics of perinatal medicine

21 January 2018

1 reference

The ethics of randomized placebo-controlled trials of antidepressants with pregnant women: a systematic review

21 January 2018

1 reference

A critical analysis of the concept and discourse of 'unborn child'.

21 January 2018

1 reference

The fetus as a patient and the ethics of human subjects research: response to commentaries on "An ethically justified framework for clinical investigation to benefit pregnant and fetal patients".

21 January 2018

1 reference

An ethical framework for conducting research on pregnant, opioid-dependent women

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ADD.12071

1 reference

2 December 2017

1 reference

PubMed ID

23331881